Biovet signs two licence agreements on innovative technologies developed in two American Universities, they will allow the diagnostic of important diseases affecting the bovine, swine and equine species. These new tests should be introduced on the international market in early 2008.

Biovet restructures its sample pick-up system for the Greater Montreal and Centre du Quebec regions thus improving its customer service in these two important regions.

Biovet is now present in Quebec City thanks to an agreement with a local laboratory. This allows Biovet to offer better service to its Greater Quebec region customers. Additionally, Biovet offers a new sample pick-up service for the Quebec and Beauce regions. These actions confirm Biovet’s commitment toward its customers in these regions.

Biovet Inc. signs a distribution agreement with Synbiotics Inc. of San Diego, US for the Canadian territory. Synbiotics Inc. is among the first specialised companies in the veterinary diagnostic market. Synbiotics'' product line is complementary to Biovet''s since it essentially targets the companion animals and poultry markets. Synbiotics is already a distributor of Biovet''s products in the United States.

Biovet Inc. announces the arrival of Dr André Broes, DMV, PhD as Director, R&D and Responsible for Technical Services for the porcine and bovine sectors. Dr Broes is recognised as an authority in porcine medicine and possesses a vast experience in porcine and bovine diagnostic. He will help define the company’s R&D strategy and will answer technical questions from Biovet’s clients.

Biovet Inc. signs a distribution agreement with Synbiotics Inc. of San Diego, US for the Canadian territory. Synbiotics Inc. is among the first specialised companies in the veterinary diagnostic market. Synbiotics'' product line is complementary to Biovet''s since it essentially targets the companion animals and poultry markets. Synbiotics is already a distributor of Biovet''s products in the United States.

Biovet Inc. successfully completes an important organisational and financial restructuring.

René Lallier, Pierre Hébert et Paule Létourneau acquire Biovet Inc. by purchasing all company shares. Dr Lallier becomes the new President and Chief Executive Officer and the majority shareholder of Biovet Inc. Dr Hébert, who had been with Biovet as clinical pathologist for a few months, becomes the new Director, Laboratory. Mrs Paule Létourneau becomes Administrative Manager.

St. Hyacinthe, Tuesday, February 24, 2004 - Biovet has closed three distribution agreements with European companies, giving it access to a European market of more than $30 million for its products. AES Laboratoires and Adiagène, located in Brittany, France, as well as the Menarini Group, based in the Netherlands, will distribute the St. Hyacinthe company’s animal diagnostic kits on the European continent. These new agreements strengthen Biovet’s presence in Europe. The company now maintains a presence in the main countries of the European Union.

Saint-Hyacinthe, September 16, 2003 - Biovet Inc., the Canadian leader in veterinary diagnostics, has just signed an agreement with Genetiporc (www.genetiporc.com), the Canadian leader in swine reproduction. The agreement represents annual revenues of $600,000. As part of this contract, some 50,000 diagnostic tests will be conducted annually on Genetiporc swine livestock. Moreover, the biotech will provide the client with its expertise in research and development, acting as their scientific advisor for Genetiporc.

Saint-Hyacinthe, Wednesday, September 10, 2003 - Biovet Inc today announced it has received its manufacturer''s establishment licence from the Canadian Food Inspection Agency (CFIA), the entity responsible for approving and regulating veterinary biological products in Canada. This licence, allocated to laboratories meeting very strict rules for the preparation, production, conservation, packaging and labelling of veterinary diagnostic kits, will now allow Biovet to manufacture, market and export kits to international markets.

Saint-Hyacinthe (QC), June 26, 2003 - Biovet Inc. today announced the integration of Laboratoire DVQ Inc. of Saint-Hyacinthe into its operations, thereby making it the largest private veterinary diagnostics company in Quebec.

St-Hyacinthe (QC), le 26 juin 2003 - Biovet Inc. a annoncé aujourd’hui l’acquisition du Laboratoire DVQ Inc. de St-Hyacinthe, devenant ainsi la plus importante entreprise du Québec dans le domaine du diagnostic animal. Cette transaction privée, dont la valeur n’a pas été dévoilée, permet de facto à Biovet d’occuper 50 % du marché des animaux de compagnie et d’offrir aux vétérinaires du Québec un service encore plus efficace et plus complet.

Saint-Hyacinthe, Friday, May 2, 2003 - Biovet Inc. today announced the beginning of construction work on a new development centre and laboratories. Financed by the Les Maskoutains Local Development Centre, the project reinforces Biovet's presence within Saint-Hyacinthe’s City of Agri food, Veterinary and Agro-environmental Biotechnology, a unique science park in the province of Quebec.

Saint-Hyacinthe, Thursday, January 30, 2003 - Biovet (www.biovet-inc.com) has added to its team of scientists, and today announced the appointment of Dr. Pierre Hébert as a clinical pathologist to its group of consulting experts. Dr. Hébert joins Biovet after spending several years in practice as a consultant and a teacher scientist. In addition to participating in the development of the company’s overall strategy, Dr. Hébert will serve as an expert to veterinarians, providing them with advice and recommendations on the best treatments to promote in order to maximize the health of their clients’ animals. Pierre Hébert will perform cytologic laboratory analyses, contribute to developing and researching new tests and technologies, and ensure the quality and reliability of test results.